Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. - Wikidata - thesis-toulmin - TriplyDB

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

http://www.wikidata.org/entity/Q36036666

about

Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan When to start antiretroviral therapy: the need for an evidence base during early HIV infection Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans.Cancer prevention in HIV-infected populations.Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Current questions in HIV-associated lung cancer.Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk Role of Natural Killer Cells in HIV-Associated Malignancies.Anal cancer: current standards in care and recent changes in practice.Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.Combination antiretroviral therapy and cancer risk.International trends in anal cancer incidence rates.Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients.Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.HIV-associated lung cancer: survival in an unselected cohort.Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination.Ageing with HIV.

P2860

Q28548473-51E04CF1-6BAB-458B-95E9-FD45D731C85C Q33593774-F8D2787B-2F7D-4D0C-BD65-100EF535D745 Q34773308-B60CEA28-51F4-4F38-BD4F-EAEA630B6DF7 Q35589818-326B83A1-BAE9-4F46-B8E9-860CDA4F83F1 Q35858493-7C597423-537B-426C-839A-01539A4043E3 Q36680086-0738D0F9-F28B-419C-89E8-F3A836CA09DE Q36957884-7B529758-28EB-44B6-AB58-A2D1B4332509 Q37085001-2D9529C8-5A6D-45D3-85B8-94FD17477005 Q37416478-60EEFE00-25FC-41BB-ABB8-19AA898B702E Q37529316-FBC04A30-B7A4-4F1A-A2CE-B907FA692DBE Q37712406-9B9122FF-55B8-4466-ACB0-2B50923026EC Q37712593-7A8F9A36-0E60-43E7-991F-457B6227D54F Q38315952-F5D8B88E-C4A5-4D2E-8B87-4D3448D8C88F Q38929040-E5EB9BF6-543F-4561-BF41-246D28176264 Q38984209-4140F316-DDBB-4FFA-BD31-8566B55F8CF2 Q39241651-4885A401-7252-4157-9772-9624EAF3084D Q40223990-1FE7A01A-BFDD-491C-B0EA-88A85A525E85 Q40252554-1BA3038C-2E61-4BE5-9902-828A8AAA9031 Q41055765-2AC0EF92-8965-4350-B27D-20B8E85C7286 Q42282227-7865A959-BF26-4AE4-86D1-CC20CAC50346 Q47133933-E141040B-BC03-4BF3-8C71-80AF5A9E680F Q50001938-C2BA908D-D493-4805-AFF4-A514D1EB2E25

P2860

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

http://www.wikidata.org/entity/Q36036666

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@ast

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@en

type

label

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@ast

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@en

prefLabel

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@ast

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@en

P1433

Q36036666-E731F6B4-CF2A-41F4-B023-D2229B6ABFAA

P1476

Q36036666-4BF964A5-90C7-45D9-86A1-19DB1350921F

P2093

Q36036666-11D32A52-DE8A-4B05-840A-A8A2B0515F29

Q36036666-566D9ACC-D48F-40DB-B8C2-CE0A183A5223

Q36036666-81711C81-495B-4F30-A6D8-7DE76F0B3A94

Q36036666-96B7FDAD-AEF3-4484-805B-0CA625034F69

Q36036666-9F9CB60D-4BB9-4A79-994B-8F37F6BFDDB7

Q36036666-AF22675B-3D6F-4790-BF69-588F78E4E7EB

Q36036666-BD4904C1-CAA6-4E42-82CC-92916997995A

Q36036666-C9E37F42-967F-41ED-A41C-1B492AB8914B

Q36036666-D2BB571B-5F82-49C3-B6AF-34886CB98B76

P2860

Q36036666-06FE1B77-C7B0-4787-BDA9-0584457FFD36

Q36036666-13375EDF-DCCF-43B9-AF90-6614B1CAD1E5

Q36036666-17C2AA02-2146-4D9F-906B-E27793FF1BC0

Q36036666-1C41B702-91FB-47B2-9A96-FD8A2642306C

Q36036666-1D1E6687-D558-4755-89BF-F62F84C2DB03

Q36036666-2098EB9F-AC1A-49E4-BDAB-01B18800BDDD

Q36036666-21C87A44-A544-46BE-A375-923DEDF773F7

Q36036666-28D51578-6D9F-4DD4-9A56-6BCE79513842

Q36036666-2C9A5BA0-7BAF-4D25-B213-D1DC259D7438

Q36036666-30FA8013-62D2-4952-8D06-F8A5D259761B

P304

Q36036666-1AA309CE-610D-4054-9E2D-59015325A3C1

P31

Q36036666-00B664D2-FA06-4D07-8AD1-6EFB105BF655

P356

Q36036666-1E53F78A-207C-43A7-AAB2-3DC427BACA37

P407

Q36036666-0185D107-780B-45F4-883F-30E3C9876AFE

P433

Q36036666-F0A6D40A-EF3B-4A93-B603-1FF28A1CBD23

P478

Q36036666-8E9F19F8-FE52-43A4-B9A8-60B3BEA99173

P577

Q36036666-F62021E1-350E-47D2-B4D5-696AA14EA2B0

P698

Q36036666-374D44ED-7AC6-40C4-AF9B-D2EF65DE3E3D

P921

Q36036666-A607A62E-EE0B-4E76-8E58-AA6E4AA6C5E9

P932

Q36036666-2ABB26B9-C89A-4E38-BAF6-27CF60DD7554

P356

QAD.0B013E32835935B3

P1433

P1476

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

@en

P2093

Charles P Quesenberry

http://www.w3.org/2001/XMLSchema#string

Chun Chao

http://www.w3.org/2001/XMLSchema#string

Daniel Klein

http://www.w3.org/2001/XMLSchema#string

Donald I Abrams

http://www.w3.org/2001/XMLSchema#string

Lanfang Xu

http://www.w3.org/2001/XMLSchema#string

Michael A Horberg

http://www.w3.org/2001/XMLSchema#string

Michael J Silverberg

http://www.w3.org/2001/XMLSchema#string

Wendy A Leyden

http://www.w3.org/2001/XMLSchema#string

William J Towner

http://www.w3.org/2001/XMLSchema#string

P2860

The global health burden of infection-associated cancers in the year 2002

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

HIV infection and the risk of cancers with and without a known infectious cause.

HIV infection is associated with an increased risk for lung cancer, independent of smoking.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.

Reduced risk of prostate cancer in U.S. Men with AIDS.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

P304

2223-2231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32835935B3

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22951631

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4562666

http://www.w3.org/2001/XMLSchema#string